Patents- NIPER, Hyderabad

HOME/ PUBLICATIONS/PATENTS/Patents

Publications / Patents >
2022 >
2021 >
2020 >
2019 >
2018 >
2017 >
2016 >
2015 >
2014 >
2013 >
2012 >
2011 >
2010/2009 >
Patents >
Book Chapters >

Patents of NIPER Hyderabad

S. No	Applicant	Title	Filing Date	Application No.
1	National Institute of Pharmaceutical Education and Research, Hyderabad	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	13/11/2025	202541110709
2	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	ENZYMATIC GREEN SYNTHESIS PROCESS OF SITAGLIPTIN PHOSPHATE MONOHYDRATE	12/11/2025	202541110208
3	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	IMMOBILIZED TRANSAMINASE, ENHANCED RECYCLABILITY, STABILITY AND APPLICATIONS	17/10/2025	202541100742
4	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	DNASE I CONTAINING NANOFORMULATIONS TO COMBAT CYTOKINE STORM VIA TARGETING NETOSIS	08/09/2025	202541084963
5	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)-HYDERABAD	INDOLE FLANKED PYRAZOLOPYRIMIDINE DERIVATIVES AS PAD-4 INHIBITING AGENTS AND METHOD OF SYNTHESIS	21/08/2025	202541079403
6	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)-HYDERABAD	2-OXO-CHROMENE-3-CARBOXYLATE DERIVATIVES AS ANTI-FIBROTIC AGENTS	21/08/2025	202541079238
7	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	PHARMACEUTICAL COMPOSITION OF CO-ENCAPSULATED ANDROGEN RECEPTOR INHIBITOR AND NUTRACEUTICAL AGENT LIPOSOMAL FORMULATION FOR PROSTRATE CANCER	16/06/2025	202541057749
8	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A PHARMACEUTICAL COMPOSITION OF COAMORPHOUS LUMEFANTRINE AND CURCUMIN FOR ENHANCED BIOAVAILABILITY AND LUNG CANCER TREATMENT	16/06/2025	202541057382
9	National Institute of Pharmaceutical Education and Research, Hyderabad (NIPER-HYDERABAD)	SPIROCYCLOPROPYL OXINDOLE DERIVATIVES AS CYTOTOXIC AGENTS AND METHOD OF ITS PREPARATION	09/06/2025	202541055478
10	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	PHARMACEUTICAL COMPOSITION OF BERBERINE AND SALT THEREOF FOR THE MANAGEMENT OF ALZHEIMER'S DISEASE	06/05/2025	202541043952
11	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	PHARMACEUTICAL COMPOSITION AND METHOD THEREOF FOR TOPICAL CO-DELIVERY OF PROSTAGLANDIN ANALOGUES AND NEUROPROTECTIVE NEUTRACEUTICAL FOR GLAUCOMA THERAPY	28/04/2025	202541040900
12	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) AND ITS METHOD OF PREPARATION	25/04/2025	202541040581
13	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	Crystallization process for selectively obtaining Needle, Plate and Block shaped crystal morphologies of Tadalafil	02/04/2025	202541032599
14	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A METHOD FOR GENERATING MICROCRYSTALS USING A POLYMER-BASED MICRODEVICE	18/03/2025	202541024202
15	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	AN EQUIPMENT-FREE PAPER-BASED MICROFLUIDIC DEVICE FOR NUCLEIC ACID EXTRACTION	13/03/2025	202541022818
16	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A CO-ENTRAPPED ALBUMIN NANOPARTICLE COMPOSITE FORMULATION FOR CANCER AND METHOD THEREOF	07/03/2025	202541020793
17	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	TOPICAL PHARMACEUTICAL COMPOSITION OF TOFACITINIB NANOSTRUCTURED CARRIER FOR THE TREATMENT OF VITILIGO	29/01/2025	202541007367
18	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A COMPOSITION AND METHOD FOR CONTROLLING PULMONARY FIBROSIS	17/01/2025	202541003971
19	National Institute of Pharmaceutical Education and Research, Hyderabad	Nanocrystal for the Bioavailability Enhancement of androgen receptor Inhibitor: Pharmaceutical Composition and Fabrication Thereof	15/01/2025	202541003359
20	National Institute of Pharmaceutical Education and Research, Hyderabad	TOPICAL DERMAL NANOEMULGEL FORMULATION OF TOFACITINIB CITRATE	06/01/2025	202541001090
21	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A MARKER CLIP FOR THE IDENTIFICATION OF TISSUE ABNORMALITIES AND METHOD THEREOF	23/12/2024	202441101799
22	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	BACTERIAL STRAIN FOR THE PRODUCTION OF CELLULASE	20/12/2024	202441101360
23	National Institute of Pharmaceutical Education and Research, Hyderabad	Pharmaceutical composition of berberine nanoemulgel for the treatment of vitiligo	05/12/2024	202441095939
24	NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), HYDERABAD	A PROCESS FOR THE PREPARATION OF MELITRACEN HYDROCHLORIDE (Formula-I) AND ITS INTERMEDIATE 10,10-DIMETHYL ANTHRONE (Formula-II)	25/11/2024	202441091898
25	National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad	A PROCESS OF IMMOBILISING CDX-036 TRANSAMINASE ENZYME ON A SUBSTRATE	18/11/2024	202441089179
26	National Institute of Pharmaceutical Education and Research Hyderabad (NIPER-H)	PHARMACEUTICAL COMPOSITION OF RUXOLITINIB AND SALT THEREOF FOR THE MANAGEMENT OF SKIN MANIFESTATIONS	04/04/2023	202341025392
27	National Institute of Pharmaceutical Education and Research Hyderabad (NIPER-H)	PHARMACEUTICAL COMPOSITION OF ROFLUMILAST FOR THE MANAGEMENT OF PSORIASIS	06/02/2023	202341007380

2023

IN 202341013877, Pharmaceutical Composition Of Pirfenidone For The Management Of Rheumatoid Arthritis, Dr. Saurabh Srivastava

IN 202341007797, Inclusion Complex And Method For Preparation Thereof, Dr. Dharmendra Khatri

IN 202341007380, Pharmaceutical Composition Of Roflumilast For The Management Of Psoriasis, Dr. Saurabh Srivastava

IN 202341004305, Enhanced Permeation And Pharmaceutical Composition Of Carbonic Anhydrase Inhibitor Loaded Ultradeformable Bile Salts Stabilized Vesicular System, Dr. Neelesh et al

2022

IN 202241064100, Antibacterial Composition Containing Oxiconazole, Dr. Srinivas Nanduri et. al

IN 202241050316, Anti-Inflammatory Composition And Method of Preparation Thereof Vaskuri G.S Sainaga Jyothi, Harithasree Veerabomma, Dr. Jitender Madan, Dr. Shashi Bala Singh, Dr. Rahul Kumar, Dr. Dharmendra Kumar Khatri

2021

IN 202141019173, Pharmaceutical composition of tofacitinib for the management of atopic dermatitis. Dr. Saurabh Srivastava et al

IN 202141007157, Substituted pyrazole compounds as antibacterial agents. Dr. Y.V.Madhavi et al

IN 202141001125, Substituted Isoxazole compounds as antibacterial agents. Dr. Y.V.Madhaviet et al.

2020

IN 202041054610, Pharmaceutical composition of thymoquinone and essential oil particulate emulsified systems and method thereof. Pratik, Mayuri Dalvi, Bhavana Valamla, Pradeep, Geetanjali, Dr. Chandraih Godugu, Dr. Shashi Bala Singh, Dr. Neelesh Kumar Mehra

IN 202041054607, Process for the synthesis of 4-benzofuran substituted quinols by Transition metal catalyzed cascade Dr. VinayKumar Kanchupalli et al

IN 202041049335, Stable Pharmaceutical Composition of Ferulic Acid and essential oil Particulate Emulsified Systems and method thereof Bhavana Valamla, Dilip Panwar, Ankaj Kumar, Pradip Thakor, Dr. Shashi Bala Singh, Dr. Neelesh Kumar Mehra

IN 202041047663, FILM FORMING TOPICAL DERMAL SPRAY OF MELOXICAM FOR THE MANAGEMENT OF PAIN AND INFLAMMATION. Vaskuri G.S Stya; Sainaga Jyothi, Jyothi Pawar, Dr Rahul Kumar, Dr. Dharmendra Kumar Khatri, Dr Shashi Bala Singh, Dr. Jitender Madan

IN 202041046470, Topical Pharmaceutical composition for treatment of psoriasis. Dr. Saurabh Srivastava et al.

IN 202041007562, Osimeritinib mesylate PLGA nanoparticles with ligands in lung cancer therapy. Anitha Sriram, Dr. Pankaj Kumar Singh, Dr. Shashi Bala Singh, Sajid Haque.

IN 202041056321, ANDROGRAPHOLIDE DERIVATIVES AS MULTITHERAPEUTIC AGENTS, Dr Srinivas Nanduri

2017

IN 201741020910, SPIROBIBENZOPYRANS AND ANALOGUES AS MULTITHERAPEUTIC AGENTS. Dr. Srinivas Nanduri et al

IN 201741010074, DRY EMULSIFYING COMPOSITION COMPRISING CURCUMINOID AND EMU OIL NAVEEN CHELLA; V. G. M. NAIDU; NALINI SHASTRI; MAHESH NAYAKULA; MANISH KUMAR JEENGAR

IN 201741003441, (E)-3-((7-Hydroxy-4-Methyl-2-oxo-2h-Chromen-8-yl)Methylene) Indolin-2-one Derivatives as anticencer Agents. Dr. Bathini Nagendra Babu (NH), G. Sravathi Devi;

IN 201741002124, N2-(4-(5-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)PHENYL)-6-MORPHOLINO-N4-PHENYL-1,3,5-TRIAZINE-2,4-DIAMINE DERIVATIVES AS ANTICANCER AGENTS. V. G. M. NAIDU (IDPL); G. JAGADEESH KUMAR (CSIR-IICT); LALITA GUNTUKU (NH); JAYATHIRTHA RAO VAIDYA (CSIR-IICT)

2016

IN 201641035739, Thiazolidinedione-vinyl benzimidazole derivatives as anticancer agents. Dr. Shankaraiah, N.; Sharma, P.; Reddy, T. S.; Kumar, N. P.; Senwar, K. R.; Bhargava, S. K.

IN 201641034481, 2-(1h-indol-3-yl)-2-oxo-acetamide derivatives as anticancer agents. Dr. Bathini Nagendra Babu (NH); G. Sravathi Devi; etc..

IN 201641002693, NOVEL FUSED TRIAZOLE COMPOUNDS AND PROCESS OF PREPARING THE SAME. Dr. Ahmed Kamal (NH); K. N. Visweswara Sastry (NH); Dr. Bathini Nagendra Babu (NH); Dr. Ram Awatar Maurya….etc (CSIR)

2015

7129/CHE/2015, Benzylideneindolinones Useful as Anticancer Agents and Process of Preparing the Same. Dr. Shankaraiah, N; Senwar, K. R.; Sharma, P.; Thummuri, D.; Naidu, V.G.M.

2014

6104/CHE/2014 patent number 371180, ANDROGRAPHOLIDE AND ANALOGUES AS MULTITHERAPEURIC AGENTS. Sai Giridhar Sarma, Nageswara Rao, Dr. Srinivas Nanduri.